2 reports

Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...

  • Diagnostics
  • Public Health
  • Genome Sequencing
  • Drug Development
  • DNA Sequencing
  • Telecommuting
  • Breast Cancer
  • Cell Therapy
  • Industrial Automation
  • Oncology
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

The global custom antibody market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period.The increasing demand for protein therapeutics is expected to drive the custom antibody market in the coming years. On the other hand, the need for significant capital investments and long...

  • Drug Development
  • Monoclonal Antibody
  • Biotechnology
  • Polyclonal Antibody
  • Infectious Disease
  • United States
  • APAC
  • Cancer Incidence
  • Direct Sales